A new medication called lenacapavir is being introduced to combat HIV. It comes in the form of a twice-a-year injection and has shown remarkable effectiveness in preventing HIV infection. Distribution of lenacapavir has begun, but its rollout is receiving mixed reviews.

Concerns are being raised about ensuring the medication reaches the areas where it is needed most. For more information on the distribution and availability of lenacapavir in San Antonio, readers can refer to the full report from Texas Public Radio. Further details are available from the source, providing a more in-depth look at the medication and its rollout.